Narnatumab Biosimilar - Anti-RON Antibody - BSA and Azide free (A318849)

Narnatumab Biosimilar - Anti-RON Antibody - BSA and Azide free

Recombinant human monoclonal antibody to RON.

ELISA: 1:5,000-10,000

Human

Human

Monoclonal

IgG1

Unconjugated

Affinity chromatography.

Reconstitution dependent.

Reconstitute with distilled sterile water.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.

c met related tyrosine kinase, CD136, CD136 antigen, CDw136, Macrophage stimulating 1 receptor, Macrophage stimulating 1 receptor (c met related tyrosine kinase), MACROPHAGE STIMULATING PROTEIN RECEPTOR, Macrophage stimulating protein receptor alpha chain, Macrophage stimulating protein receptor beta chain, Macrophage-Stimulating 1 Receptor (MST1R), Macrophage-stimulating protein receptor beta chain, MSP receptor, Mst1r, MST1R variant RON30, MST1R variant RON62, NPCA3, p185 RON, p185-Ron, Protein-tyrosine kinase 8, PTK 8, ptk8, PTK8 protein tyrosine kinase 8, Recepteur d’origine nantais (RON), RON protein tyrosine kinase, RON variant E2E3, RON_HUMAN, Soluble RON variant 1, Soluble RON variant 2, Soluble RON variant 3, Soluble RON variant 4, Stem cell derived tyrosine kinase